id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-0011-0001,FDA,FDA-2021-N-0011,Revision to Restrictions on Shipment or Use for Human Blood and Blood Components Exceptions; Technical Amendment,Rule,Final Rule,2021-09-07T04:00:00Z,2021,9,2021-09-07T04:00:00Z,,2021-09-07T13:10:03Z,2021-19220,0,0,0900006484d56736